{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:41:26Z","timestamp":1790379686134,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2556,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>\n                                 <jats:bold>Hepatocellular carcinoma (HCC) has traditionally been considered a rare complication of cirrhosis secondary to autoimmune hepatitis (AIH), yet the true incidence remains unknown due to a lack of published data. Consequently, some professional guidelines do not mandate routine surveillance for HCC in this condition. Our aims were to evaluate the rate at which HCC develops among a large, prospectively obtained cohort of patients with AIH at a single center. Demographic, clinical, and laboratory indices associated with the development of HCC were also identified. HCC was discovered in 15 of 243 patients with AIH, all of whom had type 1 AIH equating to 1090 cases per 100,000 patient follow-up years. HCC occurred in the same proportion of females as males, 6.1% versus 6.4%,<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.95. HCC occurred more frequently in patients who had cirrhosis at presentation, 9.3% versus 3.4%,<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.048, or who had a variceal bleed as the index presentation of AIH, 20% versus 5.3%,<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.003. The median duration from time of confirmed cirrhosis to a diagnosis of HCC was 102.5 months, range 12-195 months. Median survival in patients whose HCC was diagnosed on surveillance was 19 months (range 6-36 months) compared with 2 months (range 0-14 months) for patients presenting symptomatically (<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.042).<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusion:\n                                 <\/jats:bold>\n                                 <jats:bold>Cirrhosis in AIH is the<\/jats:bold>\n                                 <jats:bold>\n                                    sine qua non\n                                 <\/jats:bold>\n                                 <jats:bold>for HCC development, which subsequently occurs at a rate of 1.1% per year and affects men and women in equal proportions. (Hepatology 2008.)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.22432","type":"journal-article","created":{"date-parts":[[2008,5,27]],"date-time":"2008-05-27T16:52:21Z","timestamp":1211907141000},"page":"863-870","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":156,"title":["Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening"],"prefix":"10.1097","volume":"48","author":[{"given":"Andrew D.","family":"Yeoman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thawab","family":"Al-Chalabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Karani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Quaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Bomford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"O'Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip M.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Heneghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20241202","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma.","volume":"42","author":"Bruix","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R3-19-20241202","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R4-19-20241202","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group.","volume":"18","author":"Johnson","year":"1993","journal-title":"HEPATOLOGY"},{"key":"R5-19-20241202","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","article-title":"Azathioprine for longterm maintenance of remission in autoimmune hepatitis.","volume":"333","author":"Johnson","year":"1995","journal-title":"N Engl J Med"},{"key":"R6-19-20241202","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification.","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"R7-19-20241202","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona2000 EASL conference. European Association for the Study of the Liver.","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"R9-19-20241202","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"R10-19-20241202","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.510260508","article-title":"Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.","volume":"26","author":"Jones","year":"1997","journal-title":"HEPATOLOGY"},{"key":"R11-19-20241202","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/BF02599016","article-title":"The meaning of life expectancy: what is a clinically significant gain?","volume":"9","author":"Naimark","year":"1994","journal-title":"J Gen Intern Med"},{"key":"R12-19-20241202","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.","volume":"132","author":"El Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"R13-19-20241202","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2007.08.013","article-title":"Impact of gender on the longterm outcome and survival of patients with autoimmune hepatitis.","volume":"48","author":"AlChalabi","year":"2008","journal-title":"J Hepatol"},{"key":"R14-19-20241202","first-page":"718","article-title":"Hepatocellular carcinoma complicating autoimmune hepatitis: role of hepatitis C virus.","volume":"22","author":"Ryder","year":"1995","journal-title":"HEPATOLOGY"},{"key":"R15-19-20241202","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0168-8278(01)00062-9","article-title":"Long term benefits in sustained responders to interferonalfa therapy for chronic hepatitis C.","volume":"34","author":"Bruno","year":"2001","journal-title":"J Hepatol"},{"key":"R16-19-20241202","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0168-8278(01)00005-8","article-title":"Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidencebased approach.","volume":"34","author":"Camma","year":"2001","journal-title":"J Hepatol"},{"key":"R17-19-20241202","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-129-11_Part_2-199812011-00005","article-title":"Hemochromatosis associated mortality in the United States from 19791992: an analysis of multiplecause mortality data.","volume":"129","author":"Yang","year":"1998","journal-title":"Ann Int Med"},{"key":"R18-19-20241202","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/gast.1996.v110.pm8613000","article-title":"Long term survival in patients with hereditary hemochromatosis.","volume":"110","author":"Niederau","year":"1996","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"R19-19-20241202","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.gastro.2004.09.019","article-title":"Iron, haemochromatosis, and hepatocellular carcinoma.","volume":"127","author":"Kowdley","year":"2004","journal-title":"Gastroenterology"},{"key":"R20-19-20241202","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2003.10.048","article-title":"Hepatitis B virus maintains its prooncogenic properties in the case of occult HBV infection.","volume":"126","author":"Pollicino","year":"2004","journal-title":"Gastroenterology"},{"key":"R21-19-20241202","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/lt.500050106","article-title":"Hepatocellular carcinoma after renal transplantation in the absence of cirrhosis or viral hepatitis: a case series.","volume":"5","author":"Saeian","year":"1999","journal-title":"Liver Transpl"},{"key":"R22-19-20241202","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1523-1755.2004.00741.x","article-title":"Risk of malignancy with longterm immunosuppression in renal transplant recipients.","volume":"66","author":"Agraharkar","year":"2004","journal-title":"Kidney Int"},{"key":"R23-19-20241202","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/gut.2004.053231","article-title":"Risks and benefits of azathioprine therapy.","volume":"54","author":"McGovern","year":"2005","journal-title":"Gut"},{"key":"R24-19-20241202","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type I autoimmune hepatitis.","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology"},{"key":"R25-19-20241202","first-page":"638A","article-title":"AST at presentation: Influence on disease course and outcomes in autoimmune hepatitis.","volume":"44","author":"AlChalabi","year":"206","journal-title":"HEPATOLOGY"},{"key":"R26-19-20241202","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199306243282501","article-title":"Risk factors for hepatocellular carcinoma among patients with chronic liver diseases.","volume":"328","author":"Tsukuma","year":"1993","journal-title":"N Engl J Med"},{"key":"R27-19-20241202","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gut.7.1.77","article-title":"Cirrhosis and hepatoma in alcoholics.","volume":"7","author":"Lee","year":"1966","journal-title":"Gut"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22432","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200809000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T17:05:14Z","timestamp":1733159114000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200809000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22432","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}